Node-RADS: a systematic review and meta-analysis of diagnostic performance, category-wise malignancy rates, and inter-observer reliability - Takeaways - MDSpire

Node-RADS: a systematic review and meta-analysis of diagnostic performance, category-wise malignancy rates, and inter-observer reliability

  • By

  • Jingyu Zhong

  • Shiqi Mao

  • Haoda Chen

  • Yibin Wang

  • Qian Yin

  • Qingqing Cen

  • Junjie Lu

  • Jiarui Yang

  • Yangfan Hu

  • Yue Xing

  • Xianwei Liu

  • Xiang Ge

  • Run Jiang

  • Yang Song

  • Minda Lu

  • Jingshen Chu

  • Huan Zhang

  • Guangcheng Zhang

  • Defang Ding

  • Weiwu Yao

  • November 6, 2024

  • 0 min

Share

  • 1

    Node-RADS standardizes lymph node assessment in cancer staging, improving clarity in distinguishing between resectable and non-surgical cases.

  • 2

    The Node-RADS scoring system ranges from 1 (very low malignancy) to 5 (very high malignancy), aiding treatment decision-making.

  • 3

    Current evidence does not support the accuracy and reliability of Node-RADS in clinical practice, necessitating further evaluation.

  • 4

    This study aims to conduct a systematic review and meta-analysis to assess Node-RADS diagnostic performance and inter-observer reliability.

  • 5

    Data extraction and quality assessment were performed by experienced reviewers, ensuring a rigorous approach to the systematic review.

Original Source(s)

Related Content